-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cytek Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2020 to Q1 2025.
- Cytek Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 31 Mar 2025 was -$11,402,000.000, a 84.8% decline year-over-year.
- Cytek Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$6,020,000.000, a 50.4% increase from 2023.
- Cytek Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$12,148,000.000, a 589% decline from 2022.
- Cytek Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $2,484,000.000, a 17.9% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)